BioSpace News Archive

Drug Development

Genentech’s Tecentriq-Avastin Combo Improves Survival in Liver Cancer

Tecentriq is the company’s PD-L1 checkpoint inhibitor. Avastin is an antibody that binds to VEGF and interferes with tumor blood supply.

November 25, 2019
·
2 min read
·
Mark Terry
Career Advice

Last Minute Interview Tips To Prepare for Your Job Interview

This smooth 24 hours of preparation for your job interview should ensure a long run when you get that job offer. Here are last minute interview tips to hone your skills.

November 25, 2019
·
6 min read
·
Katharine Hansen, PhD
Pharma Integrates attracts record number of delegates

Pharma Integrates 2019, which took place on 18th and 19th November, saw over 450 delegates from biotech, pharma, CDMOs and the supply chain come together to debate and share insights on key topics currently affecting the industry.

November 25, 2019
·
2 min read
Deals

ONC201 and ONC206 Activity in Neuro-Oncology to be Presented at SNO Conference

Philadelphia, PA – Oncoceutics, Inc. announced that new data will be presented on the efficacy and mechanism of action of imipridones ONC201 and ONC206 at the 24th Annual Scientific Meeting of the Society of Neuro-Oncology, to be held November 20th-24th in Phoenix, Arizona.

November 25, 2019
·
3 min read
Genetown

Boston Globe Names Definitive Healthcare a 2019 Top Place to Work

Massachusetts Healthcare Data & Analytics Company Recognized for Third Consecutive Year

November 25, 2019
·
5 min read
Business

Rezolute Appoints Nektar Therapeutics COO & CFO to Its Board of Directors

Rezolute, Inc., a biopharmaceutical company specializing in the development of innovative drug therapies for patients with metabolic diseases, announced the appointment of Gil Labrucherie to its Board of Directors where he will serve as Chairman of the Audit Committee.

November 25, 2019
·
3 min read
Job Trends

Treatment Options for Diabetes Continue to Grow and Expand

Effective treatments for diabetes are becoming more and necessary. The past few years have demonstrated productive strides in drug therapies, such as following medications.

November 25, 2019
·
4 min read
·
Elizabeth Glasure
Business

BioSyent Signs Exclusive Agreement for Pain Management Products

BioSyent Inc. is pleased to announce that its subsidiary BioSyent Pharma Inc. has signed an exclusive License and Supply Agreement with AFT Pharmaceuticals for a portfolio of new pain management products for the Canadian market.

November 25, 2019
·
2 min read
Deals

Sonoma Pharmaceuticals Announces Proposed Public Offering of Common Stock

Sonoma Pharmaceuticals, Inc. announced the launch of a “best efforts” public offering of shares of its common stock.

November 25, 2019
·
3 min read
Deals

Alzheimer’s Research UK welcomes Tory ‘Dementia Moonshot’ funding pledge

Alzheimer’s Research UK welcomes the Conservatives’ pledge to double investment in dementia research as a ‘step in the right direction’.

November 25, 2019
·
3 min read